Actual clinical practice of guideline-recommended therapy of acute ST elevation myocardial infarction;Aktuelle umsetzung der leitlinien-konformen therapie des akuten ST-hebungsinfarkts in Deutschland

Herz

Volumn 30, Issue 8, 2005, Pages 700-703

  Wienbergen, Harm ^a   Gitt, Anselm K ^a   Senges, Jochen ^a  

^a Herzzentrum   (Germany)

Author keywords

Acute ST elevation myocardial infarction; Prehospital delay; Reperfusion therapy

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; HEPARIN; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; CLINICAL PRACTICE; CORONARY REPERFUSION; FIBRINOLYTIC THERAPY; GERMANY; HUMAN; MORTALITY; PATIENT EDUCATION; PERCUTANEOUS CORONARY INTERVENTION; PHYSICIAN; PRACTICE GUIDELINE; PROSPECTIVE STUDY; REGISTER; REVIEW; ST SEGMENT ELEVATION; TREATMENT CONTRAINDICATION; ARTICLE; EMERGENCY HEALTH SERVICE; HEART INFARCTION; HOSPITALIZATION; PROGNOSIS; STANDARD; STATISTICS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; EMERGENCY MEDICAL SERVICES; FIBRINOLYTIC AGENTS; GERMANY; HOSPITALIZATION; HUMANS; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROGNOSIS; REGISTRIES; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 28744452628     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-005-2757-7     Document Type: Review

References (17)

1. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. A report of the ACC/AHA Task Force on Practice Guidelines. J Am Coll Cardiol 2004;44:E1-E211.
2. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941-7.
3. Caputo RP, Ho KK, Stoler RC, et al. Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1997; 79:1159-64.
4. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
5. Gitt AK, Schiele R, Meiser F, et al. Myocardial infarction redefined: implication of the new definition of non-ST-segment elevation myocardial infarction on clinical practice: results of the ACOS-registry. Eur Heart J 2001;22:Suppl:3276.
6. Grassman ED, Johnson SA, Krone RJ, et al. Predictors of success and major complications for primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. J Am Coll Cardiol 1997;30:201-8.
7. Hamm CW. Leitlinien zur Therapie des akuten koronaren Syndroms mit ST-Hebungen. Z Kardiol 2004;93:324-41.
8. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13.
9. Rustige J, Schiele R, Burczyk U, et al. The 60 minutes myocardial infarction project. Treatment and clinical outcome of patients with acute myocardial infarction in Germany. Eur Heart J 1997;18:1438-46.
10. Schuster S, Koch A, Burczyk U, et al. Frühbehandlung des akuten Myokardinfarktes. Umsetzung von Therapierichtlinien in den klinischen Alltag. MITRA Pilot-phase. Z Kardiol 1997;86:273-83.
11. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003;24:28-66.
12. Wagner S, Schneider S, Schiele R, et al. Akuter Myokardinfarkt in Deutschland im Zeitraum zwischen 1996 und 1998:Therapie und hospitaler Verlauf. Ergebnisse des Myokardinfarktregisters (MIR) in Deutschland. Z Kardiol 1999;88:857-67.
13. Wienbergen H, Gitt AK, Schiele R, et al., for the MITRA PLUS Study Group. Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies. Am J Cardiol 2003;92:285-8.
14. Zahn R, Schiele R, Schneider S, et al. Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR). J Am Coll Cardiol 2000;36:2064-71.
15. Zahn R, Schiele R, Schneider S, et al. Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the maximal individual therapy in acute myocardial infarction registry and the myocardial infarction registry. J Am Coll Cardiol 2001;37:1827-35.
16. Zahn R, Zeymer U, Senges J. PTCA oder Fibrinolyse beim ST-Hebungsmyokardinfarkt (STEMI). Standortbestimmung - aktuelle Ergebnisse. Arzneimitteltherapie 2004;22:142-8.
17. Zeymer U, Gitt A, Senges J. Akuter ST-Strecken-Hebungs-Myokardinfarkt. Aktuelle Versorgungssituation der Patienten in Deutschland. Herz 2005;30:241-3.